PMC:7321036 / 46529-46720 7 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T310 | 0-16 | Sentence | denotes | (E–G) As in (B). |
| T311 | 17-191 | Sentence | denotes | Vero E6 cells treated with the AXL inhibitor gilteritinib (E), the MAPK11/14 inhibitor ralimetinib (F), or the MAPK13 inhibitor MAPK13-IN-1 (G) prior to SARS-CoV-2 infection. |